Skip to main content

previous disabled Page of 2
and
  1. No Access

    Article

    Tailoring room temperature d0 ferromagnetism, dielectric, optical, and transport properties in Ag-doped rutile TiO2 compounds for spintronics applications

    Of late, d0 ferromagnetic oxide materials have been studied as potential material for spintronics application. We investigate the crystal structure, magnetic, optical, and dielectric properties of Ag-doped TiO2 c...

    L. Chouhan, R. Narzary, B. Dey in Journal of Materials Science: Materials in… (2021)

  2. No Access

    Article

    Burdigalian to Early Serravallian Diatom Biostratigraphy from Havelock Island, Northern Indian Ocean

    In the Ritchie’s Archipelago of the Andaman group of islands (Northern Indian Ocean), Havelock Island is the largest one. The present study on diatoms has been carried out on three outcrops of Havelock Island ...

    S. Saxena, A. Chakraborty, A. K. Ghosh, R. Dey in Stratigraphy and Geological Correlation (2021)

  3. Article

    Open Access

    Eurados review of retrospective dosimetry techniques for internal exposures to ionising radiation and their applications

    This work presents an overview of the applications of retrospective dosimetry techniques in case of incorporation of radionuclides. The fact that internal exposures are characterized by a spatially inhomogeneo...

    A. Giussani, M. A. Lopez, H. Romm, A. Testa in Radiation and Environmental Biophysics (2020)

  4. No Access

    Chapter and Conference Paper

    Empirical Modelling and Optimisation of Bio-Micromachining on Antimicrobial Copper to Fabricate Micromixing System

    Bio-micromachining is upcoming future unconventional manufacturing  process. It has many benefits over other conventional as well as non-conventional process, some of them are no heat-affected zone, no recast ...

    Abhishek Singh, Arul Manikandan in Advances in Unconventional Machining and C… (2020)

  5. No Access

    Chapter and Conference Paper

    Application of Genetic Algorithm in Optimization of Hydrodynamic Bearings

    This paper presents comparison of the optimum performance characteristics of four different bearing configurations. An attempt has been made to find out the effect of four different bearing configurations of h...

    L. Roy, S. K. Kakoty in Proceedings of Fourth International Confer… (2015)

  6. Article

    Open Access

    Implications of LHCb measurements and future prospects

    During 2011 the LHCb experiment at CERN collected 1.0 fb−1 of \(\sqrt{s} = 7\mbox{~TeV}\) pp collisions. ...

    A. Bharucha, I. I. Bigi, C. Bobeth, M. Bobrowski in The European Physical Journal C (2013)

  7. No Access

    Article

    Telomere shortening, clonal evolution and disease progression in myelodysplastic syndrome patients with 5q deletion treated with lenalidomide

    G Göhring, K Lange, W Hofmann, K V Nielsen, E Hellström-Lindberg, L Roy in Leukemia (2012)

  8. No Access

    Article

    Echocardiographic predictors of symptomatic patent ductus arteriosus in extremely-low-birth-weight preterm neonates

    Identify echocardiographic parameters at ⩽4 day postnatal that predict the subsequent need for closure of a clinically significant patent ductus arteriosus (sPDA) in extremely-low-birth-weight neonates (ELBW).

    F G Ramos, C R Rosenfeld, L Roy, J Koch, C Ramaciotti in Journal of Perinatology (2010)

  9. No Access

    Chapter and Conference Paper

    The genus Dermanyssus (Mesostigmata: Dermanyssidae): history and species characterization

    The genus Dermanyssus Dugès,1834 (Mesostigmata: Dermanyssidae )includes hematophagous mites that are ectoparasites of birds.Over the years,the number of species included varied greatly:56 or more species have onc...

    L. Roy, C. Chauve in Trends in Acarology (2010)

  10. No Access

    Article

    Molecular phylogenetic assessment of host range in five Dermanyssus species

    Given that 14 out of the 25 currently described species of Dermanyssus Dugès, 1834, are morphologically very close to each another, misidentifications may occur and are suspected in at least some records. One of ...

    L. Roy, A. P. G. Dowling, C. M. Chauve, I. Lesna in Experimental and Applied Acarology (2009)

  11. No Access

    Chapter

    Molecular phylogenetic assessment of host range in five Dermanyssus species

    Given that 14 out of the 25 currently described species of Dermanyssus Dugès, 1834, are morphologically very close to each another, misidentifications may occur and are suspected in at least some records. One of ...

    L. Roy, A. P. G. Dowling, C. M. Chauve, I. Lesna in Control of Poultry Mites (Dermanyssus) (2009)

  12. No Access

    Article

    Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

    Dasatinib is an inhibitor of BCR-ABL and SRC-family kinases for patients with imatinib-resistant or -intolerant chronic myelogenous leukemia (CML). In this international phase II trial, dasatinib was administe...

    J Cortes, D-W Kim, E Raffoux, G Martinelli, E Ritchie, L Roy, S Coutre, S Corm in Leukemia (2008)

  13. No Access

    Article

    New mutations of MPL in primitive myelofibrosis: only the MPL W515 mutations promote a G1/S-phase transition

    MPL (or thrombopoietin receptor, TPO-R) 515 mutations have recently been described in 5–10% of primitive myelofibrosis (PMF) cases as decisive oncogenic events capable of triggering the disease. Here we report...

    R Chaligné, C Tonetti, R Besancenot, L Roy, C Marty, P Mossuz, J-J Kiladjian in Leukemia (2008)

  14. No Access

    Article

    Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib

    Dasatinib, a potent inhibitor of BCR–ABL in vitro, is effective for patients with chronic myelogenous leukemia (CML) resistant or intolerant to imatinib. To provide a more definitive assessment of dasatinib in ch...

    A Hochhaus, M Baccarani, M Deininger, J F Apperley, J H Lipton, S L Goldberg in Leukemia (2008)

  15. No Access

    Article

    Thérapeutiques ciblées et personnes âgées: l’exemple de la leucémie myéloïde chronique

    L’allongement de l’espérance de vie, qui touche aussi les hémopathies malignes, implique à l’heure de l’utilisation des inhibiteurs de tyrosine kinase coûteuses de définir les modalités de prise en charge des ...

    G. Martineau, L. Roy, F. Guilhot in Oncologie (2007)

  16. No Access

    Article

    Mutation status and clinical outcome of 89 imatinib mesylate-resistant chronic myelogenous leukemia patients: a retrospective analysis from the French intergroup of CML (Fi(ϕ)-LMC GROUP)

    The emergence of ABL point mutations is the most frequent cause for imatinib resistance in chronic myelogenous leukemia (CML) patients and can occur during any phase of the disease; however, their clinical imp...

    F E Nicolini, S Corm, Q-H Lê, N Sorel, S Hayette, D Bories, T Leguay, L Roy in Leukemia (2006)

  17. No Access

    Article

    Detection of JAK2 V617F as a first intention diagnostic test for erythrocytosis

    C James, F Delhommeau, C Marzac, I Teyssandier, J-P Le Couédic, S Giraudier in Leukemia (2006)

  18. No Access

    Article

    Reply to ‘Epidemiological analysis of second primary malignancies in more than 9500 patients treated with imatinib’ by Pilot et al.

    L Roy, J Guilhot, G Martineau, F Guilhot in Leukemia (2006)

  19. No Access

    Article

    Unexpected occurrence of second malignancies in patients treated with interferon followed by imatinib mesylate for chronic myelogenous leukemia

    L Roy, J Guilhot, G Martineau, R Larchée, F Guilhot in Leukemia (2005)

  20. No Access

    Article

    Quantitative HOX expression in chromosomally defined subsets of acute myelogenous leukemia

    We used a degenerate RT-PCR screen and subsequent real-time quantitative RT-PCR assays to examine the expression of HOX and TALE-family genes in 34 cases of chromosomally defined AML for which outcome data wer...

    HA Drabkin, C Parsy, K Ferguson, F Guilhot, L Lacotte, L Roy, C Zeng, A Baron in Leukemia (2002)

previous disabled Page of 2